Alzheimer's Association Global Real-World Data Platforms (ALZ-RWD) Program
Program overview
The ALZ-RWD program funds global initiatives that develop, expand, utilize and analyze real-world data (RWD) platforms' infrastructure, data and impact, building on the Alzheimer's Network for Treatment and Diagnostics (ALZ-NET). RWD platforms house data on patient health status and health care collected in real-world settings, and can support the diagnosis, prevention, treatment and care of Alzheimer's and other dementia, including efforts to identify and address health disparities.
Eligible projects may include platform development, expansion, utilization, data collection, data integration, or data analysis and publication. Priority is given to proposals that enhance harmonization and collaboration across global platforms and have the potential to advance health equity.
This grant is open to international (non-U.S.) applications.
Grant RFA
View program objectives, eligibility, submission process and more.
Pre-Submission Inquiry
This grant is open to international (non-U.S.) applications. Apply by first completing the Pre-Submission Inquiry Survey; those who meet program objectives will be invited to submit a full application.
Eligibility
- This grant is open to international (non-U.S.) applications.
- The platform must have, or plan to have, international, national or significant regional reach, and comprise a physician-enrolled or patient-enrolled registry (clinical trial databases are not eligible).
- The Principal Investigator must be a full-time faculty member or employee of the applicant organization.
- Investigators delinquent on required reports, or with prior awards closed as "Incomplete," are not eligible.
- Multiple submissions from one applicant or group are not permitted; overlapping funding with an existing Association award is not allowed.
Key dates
- Pre-Submission Inquiry Survey: accepted on a rolling basis. Surveys received by Dec. 1, 2026 will be considered for the current cycle.
- Submission of full applications will open: Dec. 1, 2026 (ProposalCentral.com)
- Application Deadline: Feb. 2, 2027 – 5 p.m. ET
- Application Review: Feb. – July 2027
- Award Notifications by Aug. 31, 2027
Funding overview
- Up to $5,000,000 has been allocated to the program; to date, $3,500,000 has been awarded.
- Individual awards range from $100,000 to $1,000,000 (direct costs only; no indirect costs allowed).
- Project duration is 12–24 months. Continued disbursement depends on progress toward key milestones.
Application process
- Pre-submission inquiries are reviewed by the Association and relevant experts; only invited applicants may submit a full application.
- Full applications, including a required data-sharing connection through GAAIN, must be submitted through ProposalCentral.
- By submitting a pre-submission inquiry or application, the applicant organization agrees to accept the program's terms and conditions of award as written.
Application review process
Please see the How to Apply for a Research Grant page for more information about the Alzheimer's Association application review process.
Additional information
For more information on eligibility, application requirements, review criteria, and reporting, please see the RFA.
Contact information
Please contact grantsapp@alz.org with any questions.